Dupilumab, an inhibitor of interleukin (IL)-4/13 activity, is a biological agent approved for the treatment of moderate-to-severe atopic dermatitis (AD)1 . Our aim was to assess the long-term effectiveness and safety of dupilumab in a clinical real-life setting.

Long-term effectiveness of dupilumab up to 52 weeks in atopic dermatitis in 253 adult patients / Nettis, E; Fabbrocini, G; Ortoncelli, M; Pellacani, G; Argenziano, G; Di Leo, E; Patruno, C; Stingeni, L; Foti, C; Rongioletti, F; Macchia, L; Tavecchio, S; Napolitano, M; Ribero, S; Bonzano, L; Calabrese, G; Di Bona, D; Nisticò, S P; Hansel, K; Romita, P; Piras, V; Carbonara, M; Detoraki, A; Ferrucci, S M. - In: BRITISH JOURNAL OF DERMATOLOGY. - ISSN 0007-0963. - 184:3(2021), pp. 561-563. [10.1111/bjd.19577]

Long-term effectiveness of dupilumab up to 52 weeks in atopic dermatitis in 253 adult patients

Fabbrocini, G;Patruno, C;Napolitano, M;Detoraki, A;
2021

Abstract

Dupilumab, an inhibitor of interleukin (IL)-4/13 activity, is a biological agent approved for the treatment of moderate-to-severe atopic dermatitis (AD)1 . Our aim was to assess the long-term effectiveness and safety of dupilumab in a clinical real-life setting.
2021
Long-term effectiveness of dupilumab up to 52 weeks in atopic dermatitis in 253 adult patients / Nettis, E; Fabbrocini, G; Ortoncelli, M; Pellacani, G; Argenziano, G; Di Leo, E; Patruno, C; Stingeni, L; Foti, C; Rongioletti, F; Macchia, L; Tavecchio, S; Napolitano, M; Ribero, S; Bonzano, L; Calabrese, G; Di Bona, D; Nisticò, S P; Hansel, K; Romita, P; Piras, V; Carbonara, M; Detoraki, A; Ferrucci, S M. - In: BRITISH JOURNAL OF DERMATOLOGY. - ISSN 0007-0963. - 184:3(2021), pp. 561-563. [10.1111/bjd.19577]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/823804
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 20
  • ???jsp.display-item.citation.isi??? 17
social impact